Roger J. S. Preston

3.5k total citations
75 papers, 1.9k citations indexed

About

Roger J. S. Preston is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Roger J. S. Preston has authored 75 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hematology, 30 papers in Immunology and 12 papers in Genetics. Recurrent topics in Roger J. S. Preston's work include Blood Coagulation and Thrombosis Mechanisms (36 papers), Platelet Disorders and Treatments (29 papers) and Complement system in diseases (19 papers). Roger J. S. Preston is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (36 papers), Platelet Disorders and Treatments (29 papers) and Complement system in diseases (19 papers). Roger J. S. Preston collaborates with scholars based in Ireland, United Kingdom and United States. Roger J. S. Preston's co-authors include James S. O’Donnell, Jamie M. O’Sullivan, Padraic G. Fallon, David A. Lane, Owen Smith, Fionnuala Ní Áinle, P. Vincent Jenkins, Orla Rawley, Barry White and Alain Chion and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Roger J. S. Preston

72 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger J. S. Preston Ireland 27 1.1k 579 309 266 253 75 1.9k
Peter A. von dem Borne Netherlands 26 1.4k 1.3× 482 0.8× 543 1.8× 327 1.2× 183 0.7× 96 2.4k
Zafer Gülbaş Türkiye 24 1.2k 1.2× 426 0.7× 240 0.8× 277 1.0× 355 1.4× 142 2.1k
Dino Veneri Italy 30 1.0k 1.0× 489 0.8× 458 1.5× 232 0.9× 136 0.5× 93 2.2k
Cristina Lupu United States 22 593 0.6× 433 0.7× 201 0.7× 340 1.3× 73 0.3× 49 1.5k
Lea M. Beaulieu United States 19 743 0.7× 478 0.8× 146 0.5× 586 2.2× 73 0.3× 23 1.8k
Heiko Rühl Germany 19 851 0.8× 320 0.6× 312 1.0× 317 1.2× 510 2.0× 92 1.8k
Davit Manukyan Germany 10 470 0.4× 723 1.2× 141 0.5× 360 1.4× 51 0.2× 17 1.6k
Carsten Deppermann Germany 21 469 0.4× 518 0.9× 141 0.5× 438 1.6× 61 0.2× 31 1.7k
Daryl S. Fair United States 27 1.2k 1.1× 363 0.6× 388 1.3× 349 1.3× 114 0.5× 61 2.5k
Gary Sinclair Canada 13 740 0.7× 1.4k 2.3× 194 0.6× 578 2.2× 137 0.5× 25 2.3k

Countries citing papers authored by Roger J. S. Preston

Since Specialization
Citations

This map shows the geographic impact of Roger J. S. Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger J. S. Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger J. S. Preston more than expected).

Fields of papers citing papers by Roger J. S. Preston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger J. S. Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger J. S. Preston. The network helps show where Roger J. S. Preston may publish in the future.

Co-authorship network of co-authors of Roger J. S. Preston

This figure shows the co-authorship network connecting the top 25 collaborators of Roger J. S. Preston. A scholar is included among the top collaborators of Roger J. S. Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger J. S. Preston. Roger J. S. Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rehill, Aisling M., Tristram A. J. Ryan, Gemma León, et al.. (2025). Trained immunity causes myeloid cell hypercoagulability. Science Advances. 11(10). eads0105–eads0105. 3 indexed citations
2.
León, Gemma, Aisling M. Rehill, James S. O’Donnell, et al.. (2025). Tissue factor-dependent colitogenic CD4+ T cell thrombogenicity is regulated by activated protein C signalling. Nature Communications. 16(1). 1677–1677. 4 indexed citations
3.
Noone, David, Roger J. S. Preston, & Gemma León. (2025). Adaptive Immunity in Immunothrombosis. Seminars in Thrombosis and Hemostasis.
4.
Preston, Roger J. S., et al.. (2024). Mimicking activated protein C-progress by PARtnering peptides. Journal of Thrombosis and Haemostasis. 22(8). 2153–2155. 1 indexed citations
5.
Chion, Alain, Ferdows Atiq, Sonia Águila, et al.. (2024). The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1. Blood. 144(13). 1445–1456. 15 indexed citations
6.
Karampini, Ellie, Helen Fogarty, Colm Bergin, et al.. (2023). Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19. Research and Practice in Thrombosis and Haemostasis. 7(2). 100085–100085. 9 indexed citations
7.
Stefańska, Anna, Gemma León, Yasmina Hernandez-Santana, et al.. (2021). SIGIRR Negatively Regulates IL-36–Driven Psoriasiform Inflammation and Neutrophil Infiltration in the Skin. The Journal of Immunology. 207(2). 651–660. 17 indexed citations
8.
Preston, Roger J. S. & Jamie M. O’Sullivan. (2021). Personalized Approaches to the Treatment of Hemostatic Disorders. Seminars in Thrombosis and Hemostasis. 47(2). 117–119. 2 indexed citations
9.
Rehill, Aisling M., et al.. (2020). Apolipoprotein A-I enhances activated protein C cytoprotective activity. Blood Advances. 4(11). 2404–2408. 6 indexed citations
10.
Rehill, Aisling M. & Roger J. S. Preston. (2020). A new thrombomodulin‐related coagulopathy. Journal of Thrombosis and Haemostasis. 18(9). 2123–2125. 3 indexed citations
11.
Preston, Roger J. S., et al.. (2019). Molecular basis of protease‐activated receptor 1 signaling diversity. Journal of Thrombosis and Haemostasis. 18(1). 6–16. 48 indexed citations
12.
O’Sullivan, Joe M., Sonia Águila, Soracha E. Ward, et al.. (2016). N‐linked glycan truncation causes enhanced clearance of plasma‐derived von Willebrand factor. Journal of Thrombosis and Haemostasis. 14(12). 2446–2457. 30 indexed citations
13.
O’Regan, Niamh, Kristina Gegenbauer, Jamie M. O’Sullivan, et al.. (2015). A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria. Blood. 127(9). 1192–1201. 36 indexed citations
14.
McGrath, Rachel T., Maartje van den Biggelaar, Barry J. Byrne, et al.. (2013). Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis. Blood. 122(25). 4107–4110. 52 indexed citations
16.
Preston, Roger J. S., et al.. (2013). Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities. Blood. 121(19). 3801–3810. 59 indexed citations
17.
Cunningham, Moya, Roger J. S. Preston, & James S. O’Donnell. (2008). Does antithrombotic therapy improve survival in cancer patients?. Blood Reviews. 23(3). 129–135. 22 indexed citations
18.
Preston, Roger J. S., Éva Ajzner, Cristina Razzari, et al.. (2006). Multifunctional Specificity of the Protein C/Activated Protein C Gla Domain. Journal of Biological Chemistry. 281(39). 28850–28857. 88 indexed citations
19.
Mollica, Luigina, Roger J. S. Preston, Alain Chion, et al.. (2005). Autoantibodies to thrombin directed against both of its cryptic exosites. British Journal of Haematology. 132(4). 487–493. 7 indexed citations
20.
Zanardelli, Sara, et al.. (2005). ADAMTS13 Substrate Recognition of von Willebrand Factor A2 Domain. Journal of Biological Chemistry. 281(3). 1555–1563. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026